Event Details
The earnings conference call, which was originally scheduled for Monday, October 26, 2026, at 06:00 P.M. (IST), has been rescheduled to 05:00 P.M. (IST) on the same date. The rescheduling is due to certain unavoidable circumstances. All other details of the earnings conference call, as communicated in the company's earlier intimation dated October 12, 2026, remain unchanged.
Conference Call Access
The link for the Q2 & H1 FY27 Earnings Conference Call is provided in the disclosure: https://mankindpharma.com/q2-h1-fy27-earnings-call